Postmenopausal estrogen therapy and serum estradiol fatty acid esters in women with and without previous intrahepatic cholestasis of pregnancy

Annals of Medicine

Volumn 36, Issue 5, 2004, Pages 393-399

  Vihma, Veera ^a   Ropponen, Anne ^a   Aittomäki, Kristiina ^a   Ylikorkala, Olavi ^a   Tikkanen, Matti J ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Cholestasis; Estradiol; Estrogen replacement therapy; Intrahepatic; Lipoproteins; Pregnancy

Indexed keywords

ESTRADIOL; ESTRADIOL VALERATE; ESTRONE; FATTY ACID ESTER; MEDROXYPROGESTERONE; SEX HORMONE BINDING GLOBULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ESTRADIOL BLOOD LEVEL; ESTROGEN THERAPY; FATTY ACID BLOOD LEVEL; FEMALE; FLUOROIMMUNOASSAY; HORMONE DETERMINATION; HUMAN; INTRAHEPATIC CHOLESTASIS; POSTMENOPAUSE; PREGNANCY DISORDER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SAPONIFICATION;

CASE-CONTROL STUDIES; CHOLESTASIS, INTRAHEPATIC; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ESTERS; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FATTY ACIDS; FEMALE; FLUOROIMMUNOASSAY; HUMANS; LIPID METABOLISM; LIPIDS; POSTMENOPAUSE; PREGNANCY; SEX HORMONE-BINDING GLOBULIN;

EID: 4544378925     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.1080/07853890410033847     Document Type: Article

References (30)

1. de Ziegler D. Is the liver a target organ for estrogen? In: Sitruk-Ware R, Utian WH, editors. The menopause and hormonal replacement therapy: facts and controversies. New York: Marcel Dekker Inc; 1991:201-26.
2. Slater CC, Hodis HN, Mack WJ, Shoupe D, Paulson RJ, Stanczyk FZ. Markedly elevated levels of estrone sulfate after long-term oral, but not transdermal, administration of estradiol in postmenopausal women. Menopause 2001;8:200-3.
3. Crook D. The metabolic consequences of treating postmenopausal women with non-oral hormone replacement therapy. Br J Obstet Gynaecol 1997;104:4-13.
4. Vihma V, Vehkavaara S, Yki-Järvinen H, Hohtari H, Tikkanen MJ. Differential effects of oral and transdermal estradiol treatment on circulating estradiol fatty acid ester concentrations in postmenopausal women. J Clin Endocrinol Metab 2003;88:588-93.
5. Hochberg RB. Biological esterification of steroids. Endocr Rev 1998;19:331-48.
6. Vihma V, Tiitinen A, Ylikorkala O, Tikkanen MJ. Quantitative determination of estradiol fatty acid esters in lipoprotein fractions in human blood. J Clin Endocrinol Metab 2003;88:2552-5.
7. Tikkanen MJ, Vihma V, Jauhiainen M, Höckerstedt A, Helisten H, Kaamanen M. Lipoprotein-associated estrogens. Cardiovasc Res 2002;56:184-8.
8. Germain AM, Carvajal JA, Glasinovic JC, Kato CS, Williamson C. Intrahepatic cholestasis of pregnancy: an intriguing pregnancy-specific disorder. J Soc Gynecol Investig 2002;9:10-4.
9. Tikkanen MJ, Adlercreutz H. Recurrent jaundice in pregnancy. III. Quantitative determination of urinary estriol conjugates, including studies in pruritus gravidarum. Am J Med 1973;54:600-4.
10. Adlercreutz H, Tikkanen MJ, Wichmann K, Svanborg A, Anberg A. Recurrent jaundice in pregnancy. IV. Quantitative determination of urinary and biliary estrogens, including studies in pruritus gravidarum. J Clin Endocrinol Metab 1974;38:51-7.
11. Kreek MJ, Weser E, Sleisenger MH, Jeffries GH. Idiopathic cholestasis of pregnancy. The response to challenge with the synthetic estrogen, ethinyl estradiol. N Engl J Med 1967;277:1391-5.
12. Drill VA. Benign cholestatic jaundice of pregnancy and benign cholestatic jaundice from oral contraceptives. Am J Obstet Gynecol 1974;119:165-74.
13. Reyes H, Ribalta J, Gonzalez MC, Segovia N, Oberhauser E. Sulfobromophthalein clearance tests before and after ethinyl estradiol administration, in women and men with familial history of intrahepatic cholestasis of pregnancy. Gastroenterology 1981;81:226-31.
14. Vihma V, Adlercreutz H, Tiitinen A, Kiuru P, Wähälä K, Tikkanen MJ. Quantitative determination of estradiol fatty acid esters in human pregnancy serum and ovarian follicular fluid. Clin Chem 2001;47:1256-62.
15. Gidez LI, Miller GJ, Burstein M, Slagle S, Eder HA. Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. J Lipid Res 1982;23:1206-23.
16. De Lignieres B, Basdevant A, Thomas G, Thalabard JC, Mercier-Bodard C, Conard J, et al. Biological effects of estradiol-17 beta in postmenopausal women: oral versus percutaneous administration. J Clin Endocrinol Metab 1986;62:536-41.
17. Scott RT, Jr, Ross B, Anderson C, Archer DF. Pharmacokinetics of percutaneous estradiol: a crossover study using a gel and a transdermal system in comparison with oral micronized estradiol. Obstet Gynecol 1991;77:758-64.
18. Steingold KA, Matt DW, De Ziegler D, Sealey JE, Fratkin M, Reznikov S. Comparison of transdermal to oral estradiol administration on hormonal and hepatic parameters in women with premature ovarian failure. J Clin Endocrinol Metab 1991;73:275-80.
19. Germain AM, Kato S, Carvajal J, Fredes A, Nien JK, Valenzuela GJ, et al. Intrahepatic cholestasis of pregnancy. A model of premature initiation of parturition. J Soc Gynecol Invest 1999;6:204A-5A.
20. Sjövall K, Sjövall J. Steroid sulphates in plasma from pregnant women with pruritus and elevated plasma bile acid levels. Ann Clin Res 1970;2:321-37.
21. Vihma V. 17β-Estradiol fatty acid esters in pregnancy serum and lipoproteins. In: Lipoprotein-associated 17β-estradiol fatty acid esters in pregnancy and during postmenopausal estrogen therapy. Helsinki: Helsinki University Press; 2003: 35-8.
22. Ory SJ, Field CS, Herrmann RR, Zinsmeister AR, Riggs BL. Effects of long-term transdermal administration of estradiol on serum lipids. Mayo Clin Proc 1998;73:735-8.
23. 3 subfraction. J Lipid Res 2002;43:392-7.
24. Leszczynski DE, Schafer RM. Metabolic conversion of six steroid hormones by human plasma high-density lipoprotein. Biochim Biophys Acta 1991;1083:18-28.
25. Pahuja SL, Hochberg RB. A comparison of the esterification of steroids by rat lecithin:cholesterol acyltransferase and acyl coenzyme A:cholesterol acyltransferase. Endocrinology 1995;136:180-6.
26. Kanji SS, Kuohung W, Labaree DC, Hochberg RB. Regio-specific esterification of estrogens by lecithin:cholesterol acyltransferase. J Clin Endocrinol Metab 1999;84:2481-8.
27. Helisten H, Höckerstedt A, Wähälä K, Tiitinen A, Adlercreutz H, Jauhiainen M, et al. Accumulation of high-density lipoprotein-derived estradiol-17beta fatty acid esters in low-density lipoprotein particles. J Clin Endocrinol Metab 2001;86:1294-300.
28. Abplanalp W, Scheiber MD, Moon K, Kessel B, Liu JH, Subbiah MT. Evidence for the role of high density lipoproteins in mediating the antioxidant effect of estrogens. Eur J Endocrinol 2000;142:79-83.
29. Gong M, Wilson M, Kelly T, Su W, Dressman J, Kincer J, et al. HDL-associated estradiol stimulates endothelial NO synthase and vasodilation in an SR-BI-dependent manner. J Clin Invest 2003;111:1579-87.
30. Li H, Förstermann U. Nitric oxide in the pathogenesis of vascular disease. J Pathol 2000;190:244-54.